213 related articles for article (PubMed ID: 3089187)
1. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
Meythaler JM; Tuel SM; Cross LL
Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin therapy in prolonged immobilization hypercalcemia.
Carey DE; Raisz LG
Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Intravenous etidronate in the management of malignant hypercalcemia.
Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients.
Ringenberg QS; Ritch PS
Clin Ther; 1987; 9(3):318-25. PubMed ID: 3111705
[TBL] [Abstract][Full Text] [Related]
7. [Hypercalcemia due to immobilization in critically ill children: calcitnonin treatment].
Urán Moreno M; Alonso Riofrío R; Moliner Robredo C; Pons Morales S; López-Herce Cid J
An Esp Pediatr; 2001 Jun; 54(6):555-8. PubMed ID: 11412402
[TBL] [Abstract][Full Text] [Related]
8. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
9. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
10. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
11. Low-dose oral etidronate therapy for immobilization hypercalcaemia associated with Guillain-Barré syndrome.
Go T
Acta Paediatr; 2001 Oct; 90(10):1202-4. PubMed ID: 11697437
[TBL] [Abstract][Full Text] [Related]
12. Immobilisation hypercalcemia.
Evans RA; Bridgeman M; Hills E; Dunstan CR
Miner Electrolyte Metab; 1984; 10(4):244-8. PubMed ID: 6087102
[TBL] [Abstract][Full Text] [Related]
13. Immobilization hypercalcemia in acute spinal cord injury treated with etidronate.
Merli GJ; McElwain GE; Adler AG; Martin JH; Roberts JD; Schnall B; Ditunno JF
Arch Intern Med; 1984 Jun; 144(6):1286-8. PubMed ID: 6428341
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin.
Alon U; Berkowitz D; Berant M
Child Nephrol Urol; 1992; 12(1):47-50. PubMed ID: 1606583
[TBL] [Abstract][Full Text] [Related]
15. Synthetic human calcitonin in refractory Paget's disease of bone.
Altman RD; Collins-Yudiskas B
Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of hypercalcemia.
Schaiff RA; Hall TG; Bar RS
Clin Pharm; 1989 Feb; 8(2):108-21. PubMed ID: 2521820
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
[No Abstract] [Full Text] [Related]
18. Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodium.
Shevrin DH; Bressler LR; McGuire WP; Kukreja SC; Kukla LJ; Lad TE
Clin Pharm; 1985; 4(2):204-5. PubMed ID: 2985326
[No Abstract] [Full Text] [Related]
19. [Immobilisation hypercalcaemia (author's transl)].
Minaire P; Meunier P; Berard E; Girard R; Bourret J
Nouv Presse Med; 1977 Dec; 6(41):3843-6. PubMed ID: 593868
[TBL] [Abstract][Full Text] [Related]
20. Combined calcitonin and oral phosphate treatment for hypercalcemia in multiple myeloma.
Brautbar N; Luboshitzky R
Arch Intern Med; 1977 Jul; 137(7):914-6. PubMed ID: 879932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
